Regeneron Hopes Its High-Dose Aflibercept Will Ease Eylea Pressure

Execs Expect BCMA Bispecific To Stand Out In Competitive Space

 
• By Alaric DeArment
  
Regeneron announced its first quarter 2023 earnings on 4 May • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business